Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    TRICHORHINOPHALANGEAL SYNDROME, TYPE II
Show Display Options
Rank Status Study
1 Completed Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Metastatic Melanoma That Has Not Responded to Previous Treatment
Condition: Melanoma (Skin)
Interventions: Biological: aldesleukin;   Biological: incomplete Freund's adjuvant;   Biological: recombinant tyrosinase-related protein-2

Indicates status has not been verified in more than two years